论文部分内容阅读
欧洲药品管理局(EMA)药物警戒风险评估委员会(PRAC)认为含有乳糖(来自牛奶的糖)的甲泼尼龙注射剂可能含有痕量牛奶蛋白,不能用于对牛奶中蛋白质有已知或怀疑过敏的患者。欧盟人用药品互认和分散程序协调小组(CMDh)随后也进一步证实,如果患者的症状恶化或出现新的症状,接受甲泼尼龙治疗过敏的患者应停止治疗。甲泼尼龙注射剂用于治疗严重的过敏反应和其他炎症症状。但已
The European Commission for Drug Control Risk Assessment (PRAC) believes that methylprednisolone injection, which contains lactose (sugar from milk), may contain trace amounts of milk protein and should not be used in foods known or suspected to be allergic to milk proteins patient. The EU Coordination Group on Mutual Recognition and Dispersal of Human Drugs (CMDh) subsequently further confirmed that patients with allergies to methylprednisone should discontinue treatment if their symptoms worsen or new symptoms develop. Methylprednisolone is used to treat severe allergic reactions and other inflammatory conditions. But already